The Global Bronchodilator Industry is on track for significant expansion, with a projected market value of US$67.8 billion by 2034. This steady growth trajectory signifies a Compound Annual Growth Rate (CAGR) of approximately 5.9% anticipated from 2024 to 2034. The current market size is estimated at US$38.2 billion in 2024, highlighting the increasing demand for these respiratory medications.